Patients Discontinuing Slimming Injections Gain Back Pounds Four Times Faster Than Those on Conventional Diets

New research indicates that people who stop using popular slimming jabs like semaglutide or tirzepatide tend to recover reduced body mass much more quickly than those who halt traditional diet and exercise regimens.

Published data in a prominent medical journal points out that while obese people often shed substantial amounts of their total mass while undergoing treatment, the mass returns at an average rate of nearly a kilo each month after stopping.

"People purchasing such medications must be cognizant of the risk of rapid weight regain when the treatment concludes," cautioned expert Dr. Susan Jebb.

This pace of recovery means a reversion to original weight in about one and a half years.

Comparing Therapies

The analysis, which looked at 37 of trials involving over 9,000 of patients, compared the outcomes of these new drugs with other pills.

Researchers point out that individuals who shed pounds through lifestyle changes alone usually experience a more gradual creep back—approximately 0.1 kg a month—post-intervention.

Explaining the Quick Rebound

Doctors propose the way of the jabs explains the accelerated rebound.

GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which controls feelings of fullness.

"Artificially providing GLP-1 levels several times higher than normal might result in the body to produce less of its own natural GLP-1, and could reduce sensitivity to its actions," said Dr. Adam Collins, a dietetics specialist.

"Withdrawal of this hormone supplement results in hunger is unsuppressed, making excessive eating far more likely."

A Chronic Disease?

The NHS suggest the jabs for people with weight-linked health risks, alongside prescribed lifestyle changes.

Professionals say that, due to the high risk of weight regain, the treatment is often ongoing.

This view is reinforced by pharmaceutical companies, who note that the findings "highlight the persistent character of obesity," similar to managing conditions like diabetes.

Patient Experiences

Individuals who have come off the jabs explain a powerful return of appetite.

"I experienced a switch flipping and you become extremely hungry," described an individual.

This difficulty is compounded if users have not adopted sustainable lifestyle or habit modifications during therapy.

Growing Use

Survey data suggest that millions of people in the UK have used these injections in the past year, with desire remaining high.

• Use is greater among women compared to males.
• The 40s and 50s age group shows the greatest usage rates.
• A large proportion access the medications through private prescriptions rather than public health services.

Finally, researchers stress that while the jabs are potent agents for shedding pounds, they are not a magic solution and maintained weight loss likely depends on combined behavioural changes.